Showing results (4641-4650 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|April 9, 2014
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patientsGeetika Srivastava, Lindsay A Renfro, Robert J Behrens, et al.
The Oncologist|April 11, 2014
Noncoding RNAs in endocrine malignancyJessica Kentwell, Justin S Gundara, Stan B Sidhu
The Oncologist|April 8, 2014
A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancerAndrew D Seidman, Stephen Chan, Jin Wang, et al.
The Oncologist|February 25, 2017
Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical OutcomeFrancesco Panzuto, Elettra Merola, Marianne Ellen Pavel, et al.
The Oncologist|March 1, 2017
Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 RearrangementMarc Wehrli, Elisabeth Oppliger Leibundgut, Heinrich H Gattiker, et al.
The Oncologist|March 10, 2017
Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-AnalysisTomohiro F Nishijima, Shlomit S Shachar, Kirsten A Nyrop, et al.
The Oncologist|March 10, 2017
Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal DoxorubicinJacopo Olivieri, Gian Piero Perna, Caterina Bocci, et al.
The Oncologist|March 10, 2017
Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid TumorsJennifer Wheler, David Mutch, Joanne Lager, et al.
The Oncologist|February 18, 2017
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer PatientsFrancesco Sclafani, Federica Morano, David Cunningham, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
Pageof 571